SCHEMBL19639348

SCHEMBL19639348

CC(C)(C)OC(=O)/N=C(\NCc1cccc(NC(=O)c2ccccc2)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 8/20 0.49
SENP5 Q96HI0 6/20 0.48
SENP2 Q9HC62 6/20 0.48
NAMPT P43490 1/20 0.47
HDAC1 Q13547 1/20 0.46
RAB9A P51151 2/20 0.46
NR1H4 Q96RI1 1/20 0.45
KCNK9 Q9NPC2 2/20 0.45
NPFFR1 Q9GZQ6 1/20 0.44
NPFFR2 Q9Y5X5 1/20 0.44
ACKR3 P25106 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNK3 O14649 1/20 0.43
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCKBR P32239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19639347 0.89 NAMPT (0.52) NAMPTHDAC1RAB9AKMT2ANPC1
SCHEMBL27113168 0.86 SENP5 (0.43) SENP1SENP5SENP2RAB9AKMT2A
SCHEMBL22227454 0.85 NR1H4 (0.51) HDAC1RAB9ANR1H4NPFFR1NPFFR2
SCHEMBL27113174 0.85 AURKA (0.43) SENP1NAMPTMAPTSMN1; SMN2CCKBR
SCHEMBL6679118 0.84 SENP1 (0.49) SENP1SENP5SENP2RAB9ANR1H4
SCHEMBL19651943 0.84 CA1 (0.51) NAMPTHDAC1RAB9AKMT2ASMN1; SMN2
SCHEMBL17902822 0.84 CA1 (0.51) NAMPTHDAC1RAB9AKMT2ASMN1; SMN2
SCHEMBL6679114 0.83 SENP1 (0.48) SENP1SENP5SENP2HDAC1NR1H4
SCHEMBL2248369 0.82 AURKA (0.41) NAMPTHDAC1NPFFR1NPFFR2MAPT
SCHEMBL10160157 0.82 SENP1 (0.55) SENP1SENP5SENP2NAMPTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342025-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS THE UNIVERSITY OF BATH (GB) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342025-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS ZYX, MPO, CFB SENP1 2986/4885SENP5 1658/4885SENP2 3428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.